Phoenix, AZ, United States of America

Michael L Bittner

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015-2016

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Michael L. Bittner

Introduction

Michael L. Bittner is a prominent inventor based in Phoenix, AZ, renowned for his groundbreaking work in the field of biomedical technology. With two patents to his name, he has made significant contributions that address pressing medical challenges, particularly in the realms of cancer treatment and radiation exposure assessment.

Latest Patents

Bittner's innovative spirit is exemplified in his latest patents. The first patent focuses on "Systems and methods for biodosimetry with biochip using gene expression signatures." This invention leverages the changes in gene expression caused by exposure to ionizing radiation, enabling the development of a self-contained radiation biodosimeter. This device can be used, for example, via a blood finger stick, facilitating easier and more efficient monitoring of radiation exposure through a fully integrated biochip.

The second patent pertains to the "Identification and treatment of cancer subsets." This invention details methods for selectively treating patients with skin squamous cell carcinoma. It emphasizes assessing the responsiveness of tumors to IP6 treatment by monitoring reduced INPP5A expression levels. Additionally, this patent offers methodologies for tracking the disease's progression and includes kits designed to aid in these assessments.

Career Highlights

Michael L. Bittner's career is marked by his collaboration with prestigious institutions such as Columbia University and The Translational Genomics Research Institute. These experiences have enabled him to refine his innovative ideas and translate them into practical applications that benefit medical science.

Collaborations

Bittner has worked alongside esteemed colleagues, including Frederic Zenhausern and Christine Orozco. His collaborations have not only enriched his own research but also fostered advancements in the broader field of genomics and cancer treatment.

Conclusion

In summary, Michael L. Bittner stands out as a key figure in innovation, particularly in the fields of biodosimetry and cancer treatment. His patents demonstrate a profound understanding of gene expression and its implications for human health, marking him as a notable inventor whose work continues to impact the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…